Abstract Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and the presence of Lewy bodies. Alpha-synuclein and its interactor synphilin-1 are major components of these inclusions. Rare mutations in the α-synuclein and synphilin-1 genes have been implicated in the pathogenesis of PD; however, the normal function of these proteins is far from being completely elucidated. We, thus, searched for novel synphilin-1-interacting proteins and deciphered periphilin as new interactor. Periphilin isoforms are involved in multiple cellular functions in vivo, and the protein is broadly expressed during embryogenesis and in the adult brain. We show that periphilin displays an overlapping expression pattern with synphilin-1 in cellular and animal models and in Lewy bodies of PD patients. Functional studies demonstrate that periphilin, as previously shown for synphilin-1, displays an antiapoptotic function by reducing caspase-3 activity. Searching for mutations in the periphilin gene, we detected a Electronic supplementary material The online version of this article
K69E substitution in two patients of a PD family. Taken together, these findings support for the first time an involvement of periphilin in PD. 
Introduction
Alpha-synuclein is a key protein in the pathogenesis of Parkinson's disease (PD) based on three missense mutations (A53T, A30P, and E46K) and multiplications of the α-synuclein locus causing autosomal dominant PD (ADPD) [1] . In addition, α-synuclein is a major component of Lewy bodies (LB) . Its biological function is not well defined yet.
It is a highly conserved presynaptic protein that is supposed to be involved in membrane fusion and budding of synaptic vesicles [1] . Its downregulation by antisense oligonucleotides caused a selective reduction of the presynaptic vesicular pool, suggesting a modulation of synaptic plasticity [2] . Moreover, the central position of α-synuclein in a complex network of pathogenic factors is apparent from its numerous interactors, e.g., Seven in absentia homolog (SIAH) 1 and 2 [3] , 14-3-3 proteins [4] , S6′ proteasomal protein (Tbp1) [5] , human dopamine transporter (hDAT) [6] , UCH-L1 [7] , parkin [8] , and mitochondrial cytochrome C oxidase (COX) [9] . The first protein which was identified as α-synuclein interactor is synphilin-1 [10] . As a component of LB in the brains of sporadic PD patients and as substrate of the E3 ligases parkin and SIAH 1 and 2, synphilin-1 provides several links to neurodegeneration in PD [11] . However, there is still not much known about its physiological functions. The cytosolic 919-amino acid (aa) protein contains several motifs propagating protein-protein interactions, namely ankyrin-like repeats, a coiled-coil domain, and an ATP/GTP-binding domain [10] , supporting a role of synphilin-1 as adapter molecule. Importantly, synphilin-1 displays an antiapoptotic function in the control of cell death [12] . The authors showed that synphilin-1 protects neuronal and Human Embryonic Kidney (HEK 293) cells from staurosporine-and 6-hydoxydopamine (6-OHDA)-induced toxicity by reducing caspase-3 activity and poly(ADPribose) polymerase (PARP) cleavage and by diminishing both p53 expression and transcriptional activity. Interestingly, synphilin-1 is cleaved by caspase-3, and it is the C-terminal caspase-3-derived fragment that is responsible for its antiapoptotic phenotype [12] .
We recently identified a novel R621C substitution in the synphilin-1 gene in two sporadic PD patients which represents a potential susceptibility factor for PD as it mediates toxicity in different paradigms of cellular stress in vitro [13] . To further elucidate the role of synphilin-1 in the pathogenesis of PD, we executed a yeast two-hybrid (Y2H) screening and identified periphilin as novel interactor of synphilin-1. Periphilin displays a high degree of functional diversity which is in part ascribable to the fact that the human periphilin gene at chromosome 12q12 contains 14 exons, of which exons 2, 4, 7, and 11-14 are subject to alternative splicing in a tissue-specific manner [14] . Periphilin has been previously described as potential constituent of the keratinocyte cornified envelope [14] and as gastric cancer-associated gene [15] . Another isoform retards S phase progression through repression of both messenger RNA (mRNA) and protein expression of Cdc7 [16, 17] . Periphilin-deficient mice with a gene trap insertion in the murine periphilin-1 gene revealed that the gene is broadly expressed during embryogenesis and in the adult brain and that periphilin is indispensable for murine development and viability [18] . However, no report has ever linked periphilin to PD before. The interaction with synphilin-1 prompted us to investigate whether periphilin might play a role in the pathogenesis of PD applying immunohistochemical studies on human PD brain, cytotoxicity tests, and mutation analyses.
Materials and methods
Yeast two-hybrid assays and yeast culture
The bait construct for Y2H screening was generated as fusion construct encoding aa 177-348 and 557-920 of synphilin-1 in the pLEXA-DIR vector (Dualsystems Biotech AG, Switzerland). The central ankyrin-like repeats, the coiled-coil domain, and the ATP/GTP-binding domain were omitted to avoid unspecific interactions. The first 176 aa of synphilin-1 were truncated since they caused self-activation of the 5′ construct due to their acidic nature [19] . Selfactivation was assayed by cotransformation of the bait together with a control prey. The bait construct was cotransformed with a human brain complementary DNA (cDNA) library into yeast strain L40 (MATa his3_200 trp1-901 leu2-3,112 ade2 LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ GAL4) using standard procedures [20] . Positive transformants were tested for β-galactosidase activity using a filter assay [21] . Library plasmids were isolated from positive clones and retransformed into L40 with (1) the bait plasmid and (2) a control bait encoding a LexA-lamin C fusion. Positives that showed β-galactosidase activity when coexpressed with the bait but not when coexpressed with the control bait were considered to be bait-dependent positive interactors. The identity of positive interactors was determined by sequencing.
For pairwise interaction tests, plasmids encoding periphilin-GAL4 and 5′ (aa 177-348) or 3′ (aa 557-920) portions of synphilin-1 fused to a LexA-binding domain were generated using SalI and NotI restriction sites of pBTM117c [22] and pGAD426 (kindly provided by Erich Wanker, MDC Berlin, Germany). The prey vector pGAD426 containing an upstream GAL4 activation domain had been modified from pGAD424 (BD Biosciences Clontech, Germany). The cloning of periphilin from pooled human brain cDNA is described in the following subsection. The periphilin K69E mutation was inserted using the QuickChange® Site-Directed Mutagenesis Kit (Stratagene, The Netherlands). Primer sequences for cloning and sequencing are available from the authors. The generation of periphilin deletion constructs, that were kindly provided by Sirpa Aho (Thomas Jefferson University, Philadelphia, USA) has been described elsewhere [14] . Constructs referred to as encoding aa 87-374, 197-374, and 197-349 in this former publication correspond to encoded aa 25-313, 136-313, and 136-287 in our numbering, respectively. Plasmids were cotransformed into L40 and grown at 30°C for 3 days on synthetic media without leucine and tryptophan. The β-galactosidase reporter activity was assayed on nitrocellulose filters by incubating freezefractured colonies in Z-buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , pH 7.0) containing 34.6 mM β-mercaptoethanol and 0.65 mM X-gal at 37°C for 15 min to 19 h. Self-activation was assayed as described above.
Cloning of periphilin complementary DNA Periphilin was amplified from cDNA obtained from human brain by RNA isolation and reverse transcriptionpolymerase chain reaction (RT-PCR). To allow the amplification of all known splice variants, a 5′ primer complementary to the 5′ untranslated region (5′UTR) upstream of the first splice site was chosen. Similarly, an unspecific T7-(dT) 24 primer was used to facilitate the amplification of all periphilin splice variants. The polymerase chain reaction (PCR) was carried out using the Expand Long Template PCR System (Roche, Germany) according to the manufacturer's instructions. The amplicon was purified with the QIAquick Gel Extraction Kit (QIAGEN, Germany) and 5′ and 3′ terminal sequences were sequenced. Subsequently, primer pairs containing SalI and NotI restriction sites were designed to facilitate cloning into Y2H bait and prey plasmids. Primer sequences are available from the authors on request.
V5-tagged expression constructs
To prepare C-terminally V5-tagged periphilin expression constructs, periphilin was amplified via PCR from fulllength periphilin in pBTM117c. The applied primer pairs incorporated HindIII and XhoI restriction sites to facilitate subcloning in the expression plasmid pcDNA3.1/V5-His®A (Invitrogen, Germany); primer sequences are available on request. The insert DNA was sequenced to obviate PCR-generated errors.
Cell culture and transfection HEK 293 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Germany) supplemented with 10% fetal calf serum (FCS) and 1% penicillin/streptavidin in a 5% CO 2 atmosphere. For transient transfections, cells were plated on 6-well plates and transfected with Lipofectamine (Invitrogen, Germany) in a ratio of 2 µg DNA to 5 µl Lipofectamine.
Generation of a periphilin-specific antibody
The generation of an antibody specific for periphilin was described previously [18] . Briefly, the antigenic peptide RSKAIASKTKEIEQVYRQD was synthesized as single peptide and as multiple antigen peptide (MAP) (RSKAIASKTKEIEQVYRQD)8-(Lys)4-(Lys)2-Lys-Gly-OH [23] using standard Fmoc/tBu chemistry [24] on a multiple peptide synthesizer Syro II (MultiSynTech, Germany). The peptides were purified using reversed phase highperformance liquid chromatography (HPLC), and the identity was confirmed using electrospray ionization mass spectrometry (ESI-MS). Peptide purities were determined via analytical HPLC and proved to be greater than 90%. The single peptide was coupled to keyhole limpet hemocyanin (KLH) using the glutardialdehyde method.
The antiserum (1,313/1) was obtained after repeated immunization of a rabbit with a 1:1 mixture of the peptide-KLH-conjugate and the MAP and further purified by affinity chromatography on a CH-activated Sepharose 4B (GE Healthcare, Germany) containing the immobilized peptide via a stable peptide bond. The antiserum was applied onto the column at 0.5 ml/min and recycled overnight. The column was washed with 20 column volumes of phosphate-buffered saline (PBS). Elution was performed with 10 volumes of 0.1 M glycine/HCl (pH 2.5). Antibody containing fractions were immediately neutralized with 1 M Tris/HCl (pH 8.5) and concentrated on a 20-kD membrane. The resulting antibody was retested in an enzyme-linked immunosorbent assay (ELISA) and showed the expected specificity.
Solubilization of periphilin protein
Periphilin extraction from cells To extract V5-tagged periphilin from cell cultures, transiently transfected HEK 293 cells were washed 48 h after transfection with cold PBS and harvested with a radioimmunoprecipitation (RIPA) buffer as described elsewhere [14] .
Periphilin extraction from postmortem tissue Brain tissue of one male who died of PD at the age of 63 and one male who died from cardiorespiratory insufficiency at the age 59 was obtained from a brain bank established at the Institute of Brain Research at the University of Tuebingen, Germany. Both individuals had signed an informed consent. To proof the interaction of endogenous periphilin with synphilin-1, the cortex of an adult mouse transgenic for myc-tagged synphilin-1 was dissected. A small piece of the human frontal cortices and the entire murine cortex were thawed on ice and 1 ml (for the human samples) or 500 µl (for the murine sample) TES buffer (50 mM Tris-HCl pH 7.5, 2 mM EDTA pH 8.0, 100 mM NaCl; protease inhibitor Complete, Roche, Germany) were added. The tissue was chopped up with an UltraTurrax® (IKA Works, Inc., Wilmington, NC, USA). Subsequently, 100 µl (for the human samples) or 50 µl (for the murine sample) of TES containing 10% NP-40 (IGEPAL CA-630, Sigma, Germany) were added. The samples were mixed and incubated on ice for 40 min. After centrifugation (16.100g, 10 min, 4°C), the supernatant was harvested and centrifuged again for 20 min under the same conditions. The supernatant was frozen at −80°C under addition of 10% glycerol (Roth, Germany).
Immunoprecipitation
Postmortem tissue was lysed as described above. Precipitation was carried out according to manufacturer's instructions using anti-c-myc Agarose affinity gel (Sigma, Germany) for the precipitation of myc-tagged synphilin-1 from the cortex lysate of a synphilin-1 transgenic mouse.
Western blot analysis
For Western blotting, 50 µg of cell or tissue lysates or supernatants from immunoprecipitation experiments (see above) were denatured and separated through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nylon membranes. The membranes were blocked in 5% nonfat dry milk powder in Tris-Buffered Saline (TBS). After incubation with rabbit anti-periphilin antiserum (1,313/1; 1:1,000 in TBS with 5% nonfat dry milk powder), mouse anti-myc antibodies (Santa Cruz sc-40,1:200 in TBST), or mouse anti-actin antibodies (Santa Cruz sc-8,432; 1:200 in PBS with 5% nonfat dry milk powder), the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (anti-rabbit, 1:3,000; anti-mouse, 1:2,500; Amersham Biosciences, Sweden) and developed using ECL TM Western Blot Detection Reagents (Amersham Biosciences).
Immunofluorescence microscopy HEK 293 cells were grown on Poly-L-Lysine coated slides and transfected with 2 µg of FLAG-tagged wild-type (wt) synphilin-1 using Lipofectamine (Invitrogen, Germany) in a ratio of 2 µg DNA to 5 µl Lipofectamine. Thirty hours after transfection, cells were washed with PBS, fixed with 4% paraformaldehyde (PFA), and permeabilized with 100% methanol. After washing with PBS, cells were incubated for 30 min in 10% normal donkey serum (NDS) in PBS. Then, cells were labeled overnight at 4°C with rabbit 1,313/1 anti-periphilin antiserum (1:80) and mouse anti-FLAG monoclonal antibody (Sigma, Germany, 1:500) in PBS containing 5% NDS. Next day, cells were washed with PBS and labeled with Cy2-conjugated anti-rabbit (1:300) and Cy3-conjugated anti-mouse (1:500) secondary antibodies (Dianova, Germany). The slides were analyzed under a laser scanning microscope (LSM 510 Meta, Zeiss, Germany). The images were stored and processed with the LSM Image Browser (Zeiss, Germany).
Subcellular fractionation
Subcellular fractionations were carried out as described [25] . Briefly, brains of five adult rats were pooled and homogenized in buffer containing 0.32 M sucrose, 4 mM Hepes, pH 7.4, and protease inhibitor cocktail (Complete, Roche, Israel). The crude homogenate (H) was centrifuged for 10 min at 800 g, producing the P1 pellet. The supernatant (S1) was centrifuged for 15 min at 9,200 g, producing the pellet P2 and supernatant S2. P2 was washed once with the original volume of homogenization buffer and centrifuged for 15 min at 10,000 g to produce the final P2 pellet. S2 supernatant was centrifuged for 2 h at 165,000 g to give the supernatant S3 and pellet P3. Washed P2 was resuspended in a small volume of homogenization buffer and lysed hypotonically with 9 vol. ice-cold water containing a cocktail of protease inhibitors. The pH was quickly adjusted by the addition of concentrated Hepes, pH 7.4. The lysed P2 was centrifuged for 20 min at 25,000 g, giving rise to the supernatant LS1 and pellet LP1. LS1 was centrifuged for 2 h at 165,000 g, producing the supernatant LS2 and the crude synaptic vesicle fraction LP2. Protein samples (50 µg) were denatured for 5 min at 100°C in sodium dodecyl sulfate (SDS) sample buffer and analyzed by Western blot using anti-periphilin (1,313/1), anti-synphilin-1 [10] , and anti-actin (Santa Cruz) antibodies.
Immunohistochemistry of adult human brain
Staining for LB was carried out on formalin-fixed, paraffinembedded 4-µm thick sections using the avidin-biotinimmunoperoxidase technique. Sections were deparaffinized, and endogenous peroxidase activity was blocked with 0.3% H 2 O 2 in 0.05% TBS for 20 min. After washing in 0.05% TBS, sections were brought to 5% bovine serum albumin (Gibco BRL, Grand Island, NY, USA) and 0.3% Triton X-100 (Biochemica, Germany) for 1 h at room temperature (RT). Sections were then incubated with the affinity-purified rabbit anti-periphilin antibody (1,313/1, see section antibody generation), diluted 1:10 in 0.05% TBS containing 3% bovine serum albumin overnight at 4°C. Next day, sections were washed with 0.05% TBS, incubated in biotinylated goat anti-rabbit IgG (StrAviGen multi-Link Kit, BioGenex, San Ramon, CA, USA), diluted 1:200 in 0.05% TBS for 1 h at 4°C, rinsed in 0.05% TBS, and then incubated for 45 min at 4°C in StreptABComplex/HRP (Dako, Glostrup, Denmark). The enzymatic reaction was carried out with 4% 3-amino-9-ethylcarbazole (AEC, BioGenex, San Ramon, CA, USA). Sections were counterstained with hematoxylin for 20 s. To confirm specificity of the immunostaining, the periphilin antibody was preadsorbed overnight with peptide solution (2 mg peptide per ml in 0.05% TBS) and used to stain a control section.
Mutation analysis
Exon sequences and exon-intron boundaries from eight index patients of four families with PD were amplified and sequenced with the BigDyeTerminator Cycle sequencing kit 3.1 (ABI, Germany) on an ABI 3730 sequencer. Primer sequences are available from the authors on request. Two of these families had been linked to the PARK8 locus and had been previously characterized clinically and pathologically [26] . Two other small families showed owing to their size only weak linkage to PARK8. In order to confirm the detected 205A > G point mutation, additional 323 sporadic and 38 familial PD patients from clinical centers in Munich and Tuebingen were screened. In all patients, PD was diagnosed clinically by specialists in movement disorders according to the UK Parkinson's Disease Society Brain Bank criteria. After obtaining informed consent, blood samples were drawn for DNA extraction. These PD patients had a male:female ratio of 1.38 and showed a median age at onset of 55.4±19.1 years. Fig. 1 Schematic presentation of periphilin and synphilin-1 cDNA. a The box represents full-length periphilin cDNA with its 14 exons. The exons lacking in the coding sequence (CDS) under investigation due to alternative splicing are represented by gray boxes. Exon 1 is part of the 5′UTR and is represented by a striped pattern. The arrowhead indicates the newly identified mutation K69E in exon 6 of the periphilin cDNA. Lines represent the fragments of periphilin used as prey in pairwise Y2H interaction tests. Amino acids are numbered consecutively from the first translated in-frame start codon in exon 3, skipping the amino acids of exon 4 deleted by alternative splicing. b The synphilin-1 cDNA is represented as box. The ankyrin-like repeats, the coiled-coil domain, the ATP/GTP-binding domain, and the R621C substitution are indicated. Lines mark the synphilin-1 fragments used as bait in pairwise Y2H interaction tests Four hundred healthy age-and sex-matched individuals from a population-based cohort panel served as controls.
Caspase-3 activity measurements
Stable synphilin-1 transfectants or mock-transfected HEK 293 cells were transiently transfected with wt or mutant V5-periphilin or empty pcDNA3.1/V5-His®A vector as negative control and preincubated without or with 200 µM 6-OHDA for 6 h, and then caspase-3-like activity was fluorimetrically measured as detailed by Giaime and coworkers [12] . Caspase-3-like activity is considered as the Ac-DEVD-CHO-sensitive Ac-DEVD-7-amino-4-methylcoumarin-hydrolyzing activity. 
Results

Identification of periphilin as interactor of synphilin-1
Using a LexA-based Y2H screen, we identified periphilin as interactor of synphilin-1. To test the interaction between synphilin-1 and a brain-specific periphilin isoform, periphilin cDNA was isolated from human brain. The coding sequence (CDS) has a total length of 939 base pairs encoding 313 aa and lacks exon 1 as part of the 5′ untranslated region (5′UTR) and exons 2, 4, and 12-14 due to alternative splicing (Fig. 1a) . The exclusion of exon 2 deletes the first in-frame translation initiation codon; the second ATG is referred to as Met-1 in our numbering. In pairwise Y2H interaction tests, we cotransformed plasmids encoding periphilin (aa 1-313) fused to a GAL4 activation domain and fragments of synphilin-1 (aa 177-348 or 557-920) fused to a LexA domain into yeast strain L40 (Fig. 1) . The first 176 aa of the synphilin-1 protein were deleted since they caused self-activation due to an acidic activation domain. No interaction was observed between the truncated 5′ synphilin-1 construct and periphilin (data not shown). In contrast, cotransformation of the 3′ region of synphilin-1 (aa 557-920 of wt and R621C synphilin-1) revealed a strong β-galactosidase reporter activity indicating an interaction between periphilin and both synphilin-1 variants (Fig. 2) . The K69E mutation (described in the last section) in the periphilin gene of two PD patients did not affect the interaction (Fig. 2) . Fine mapping of the periphilin interaction site proved that the carboxy-terminal (C-terminal) portion of synphilin-1 (both wt and R621C) interacts with aa 25-313 and 136-313 of periphilin but not with aa 136-287, indicating that aa 288-313 are necessary for synphilin-1-binding in yeast (Fig. 2) .
To confirm the interaction with an independent method in an in vivo situation, we immunoprecipitated synphilin-1 from transgenic mice overexpressing myc-tagged human synphilin-1 (S. Nuber, personal communication) and were able to show coimmunoprecipitation of endogenous periphilin protein (Fig. 3) . Additionally, the periphilin-synphilin interaction was validated with an immunodepletion assay with lysates from HEK 293 cells overexpressing V5-tagged periphilin and FLAG-tagged synphilin-1 showing that synphilin-1 is depleted from the supernatant after immunoprecipitation of periphilin (Supplementary material Fig. S1 ). This firmly underlines the interaction of both proteins and shows that also endogenous periphilin interacts with synphilin-1 in vivo.
Overlapping cellular localization of periphilin and synphilin-1
We investigated if the two proteins share similar subcellular compartments in vitro and in vivo. Confocal laser scanning microscopy revealed endogenous periphilin predominantly in the cytoplasm of HEK 293 cells (Fig. 4a) . However, a weak staining was also apparent in the nucleus. Synphilin-1 shows a similar cellular distribution as it also localizes to the cytoplasm (Fig. 4b, c) , as previously described [10, 13] . Since HEK 293 cells are nonneuronal cells and synphilin-1 is primarily a synaptic protein, the subcellular distribution of periphilin and synphilin-1 was further investigated in adult rat brain. To this end, subcellular fractions were obtained by a series of differential centrifugations of adult rat brain homogenate. This analysis demonstrated that periphilin and synphilin-1 show partial colocalization in the rat brain (Fig. 4d) . In particular, periphilin was present in LP2, the fraction that contains synaptic vesicles, where synphilin-1 is enriched. The enrichment of synphilin-1 being an established presynaptic protein serves at the same time to prove the accuracy of this fraction [25] . In accordance with the immunofluorescence analyses, both proteins were also present in the cytosolic fraction S3, whose purity was proven by staining with anti-beta-actin antibodies as cytosolic marker (Fig. 4d) . Although periphilin was not enriched in the LP2 fraction like synphilin-1, the presence of periphilin in this fraction suggests that periphilin and synphilin-1 may interact at the presynaptic terminal. Fig. 3 Interaction of endogenous periphilin and synphilin-1 in a mouse model transgenic for synphilin-1. Synphilin-1 was immunoprecipitated from cortex lysate of a mouse transgenic for human myc-tagged synphilin-1 using agarose-conjugated c-myc antibodies. Subsequently, synphilin-1 and periphilin immunoreactivity were monitored applying myc-or anti-periphilin (1,313/1) antibodies, respectively. The figure shows that periphilin specifically coimmunopreciptates with synphilin-1. As negative control, the same cortex lysate was immunoprecipitated with agarose-conjugated V5 antibodies, which yielded neither a signal for synphilin-1 nor periphilin Periphilin is expressed in the cortex of PD patients and healthy controls and is a component of Lewy bodies Western blot analyses of lysates derived from postmortem human brains revealed no differences in the cortical periphilin expression between a PD patient and a control individual with no evidence of neurological disease (Fig. 5c ). This applies both to the expression level and protein size, excluding posttranslational cleavage of the periphilin protein in this brain region.
In brains of PD patients, about 30% of the LB showed a prominent staining (Fig. 5a) . Preadsorbtion of the antibody with the antigenic peptide in a molar ratio of 1:900 completely blocked the signal (Fig. 5b) indicating that it is specific for periphilin. In control sections of the substantia nigra of patients without PD, faint immunoreactivity was observed primarily in the neuronal cytoplasm, axons, and neurites, respectively.
Identification of a K69E substitution in two related PD patients of one family Searching for periphilin mutations in familial PD, we sequenced the periphilin gene in eight symptomatic members of four PD families. The periphilin gene maps to human chromosome 12q12 close to the former candidate region of PARK8. By the time we started our analyses, the PARK8 gene had not been cloned yet. We, therefore, preferentially selected families with linkage to the PARK8 locus. In a small family compatible with ADPD but due to its size only with suggestive linkage to PARK8, we identified a heterozygous 205A > G sequence variant leading to an aa exchange from K to E at position 69 in two affected cousins (individuals 305 and 306 in Fig. 6a) . Pedigree details and clinical data are provided as supplementary data (Supplementary material Fig. S2 ). Two further symptomatic family members deceased, and DNA is not Synphilin-1 was found to be enriched in the high-speed pellet of the lysed synaptosomal fraction (LP2), which is a fraction enriched in synaptic vesicles. As synphilin-1 is an established presynaptic protein, the enrichment in LP2 proves the accuracy of this fraction. Periphilin is also found in this fraction even though it is not enriched in LP2. In accordance with the immunofluorescence analyses, both proteins are also present in the cytosolic fraction S3. The purity of this fraction was shown by labeling with anti-beta-actin antibodies. H homogenate, S1 supernatant of the homogenate at low-speed centrifugations and corresponding pellet P1, P2 crude synaptosomes pellet of S1 and corresponding supernatant S2 at medium-speed centrifugations, P3 pellet of S2 and corresponding supernatant of S3 at high-speed centrifugations, LP1 pellet obtained after hypotonic lysis of P2 and corresponding supernatant LS1, LP2 vesicle-enriched pellet of LS1 and corresponding supernatant LS2 available. Three unaffected family members were also tested and do not carry the mutation. Genotyping the 205A > G point mutation in additional 323 sporadic and 38 familial PD patients and in 400 controls did not identify any additional carrier of this mutation. For the two affected cousins, mutations were excluded in the LRRK2 gene (PARK8 gene) and in 29 other genes of the PARK8 region [27] .
An orthologue of human periphilin is found in mouse, rat, chicken, and Xenopus, but not in Drosophila and Caenorhabditis elegans. The corresponding proteins share 50% (Xenopus) to 85% (rat) identity with the human protein. The lysine residue at position 69 is conserved in human, mouse, rat, and chicken, supporting a functional relevance of this mutation (Fig. 6b) , which remains to be defined by further studies.
Periphilin displays an antiapoptotic function, both under basal conditions and under 6-OHDA treatment Stable synphilin-1 transfectants or mock-transfected HEK 293 cells were transiently transfected with periphilin (wt or mutant) or empty vector and pretreated without or with 6-OHDA. As shown in Fig. 7a (left side) , periphilin significantly reduced caspase-3 activity under basal conditions and 6-OHDA treatment (p<0.05). Furthermore, synphilin-1 significantly downregulated caspase-3 activity in HEK 293 cells both under basal (p<0.05) and 6-OHDAinduced (p<0.001) conditions, as shown previously [12] . In stable synphilin-1 transfectants, no synergistic antiapoptotic effect could be observed upon cotransfection of periphilin (Fig. 7a, right side) , neither under basal conditions nor under 6-OHDA stimulation. For both single-and doubletransfected cells, no significant differences were evident between wt and K69E periphilin transfected cells, neither under basal conditions nor under 6-OHDA treatment.
Discussion
We establish periphilin as novel component of the protein network related to PD based on (1) its interaction and colocalization with the α-synuclein interacting protein synphilin-1, (2) its presence in LB, (3) the functional implication of periphilin in the control of cell death, and (4) the identification of a missense mutation in two cousins suffering from PD. Moreover, previous studies demonstrated that periphilin is highly expressed in dopaminergic neurons of the substantia nigra pars compacta and the ventral tegmental area, brain regions severely affected in PD [18] .
The highly insoluble periphilin protein has been described as interactor of periplakin, a protein involved in the differentiation of epidermal keratinocytes [14] . Periphilin is Fig. 5 Periphilin expression in human brain. a Staining of two Lewy bodies (LB) in a neuromelanin (NM) containing neuron using an antibody directed against periphilin (1,313/1). The immunoreacticity is most prominent in the halo, but also visible in the core. b Neither staining of the LB nor any other structures is visible after preadsorbtion of the primary antibody. c Periphilin is expressed in the postmortem cortex of a PD patient and a control individual with no obvious difference regarding the expression intensity and no indication for differences in posttranslational processing found in nuclear granules and at the nuclear membrane of undifferentiated keratinocytes, as well as at the cell periphery and cell-cell junctions of differentiated keratinocytes. Different isoforms of periphilin are expressed in human brain, kidney, liver, lung, pancreas, placenta, heart, and skeletal muscle [14] . Here, we confirm the expression of periphilin in human brain by cloning periphilin from pooled human brain cDNA, by detecting periphilin in LB of PD patients (Fig. 5a) , and by expression analyses of human brain lysates (Fig. 5c) . The periphilin isoform studied in this work lacks exons 1, 2, 4, and 12-14 (exon 1 as part of the 5′UTR, the remaining exons due to alternative splicing) and is, therefore, identical to the keratinocyte-specific isoform described before [14] . Other tissue-specific isoforms have been described, arising from alternative splicing of exons 2, 4, 7, and 11-14 [14] . Functional differences of these isoforms need to be clarified by future experiments.
We identified the interaction between periphilin and the α-synuclein-interacting protein synphilin-1 using a yeast two-hybrid approach. The interaction occurs in a region spanning from aa 557-920 in the synphilin-1 protein and aa 288-313 in the periphilin protein (Fig. 2) . The interacting domain of synphilin-1 is, therefore, different compared to other synphilin-1 interactors that bind to the central region of synphilin-1. Amino acids 349-555 have been shown to be necessary and sufficient for the interaction with α-synuclein, and the strongest interaction with parkin has been observed with aa 214-556 of the synphilin-1 protein [11] . Similarly, dorfin interacts with synphilin-1 through its central portion [28] . The minimal binding region of the E3 ligases SIAH 1 and SIAH 2, however, is constituted by the first 202 (SIAH 1) or the first 227 (SIAH 2) aa, respectively [11] . The C-terminal part of the synphilin-1 protein, which is necessary and sufficient for the interaction with periphilin, contains the fifth and sixth ankyrin domain and the R621C substitution. This exchange, however, does not cause a differential interaction with periphilin. In the periphilin protein, the C-terminal region is essential for the interaction with synphilin-1. The last 110 aa are responsible for the homodimerization of periphilin [14] . The deletion of the last 25 aa that are indispensable for the periphilinsynphilin interaction not only completely abolishes the interaction with synphilin-1 but also this self-interaction. The ability to dimerize might change protein solubility properties which could be a prerequisite for the interaction with synphilin-1. (Xl) share between 85% (human/rat) and 50% (human/Xenopus) identities. No homologues were detected in Drosophila and Caenorhabditis elegans. Identities through all species are shown in red, and the position of the mutation is highlighted in green. The wild-type residue lysine (K) is conserved in mouse, rat, and Gallus. In Xenopus, it is replaced by the similar amino acid arginine Next, we confirmed the physical interaction between periphilin and synphilin-1 in vivo. Overexpressed myctagged synphilin-1 from a synphilin-1 transgenic mouse model was enriched to specifically pull down endogenous periphilin from mouse brain (Fig. 3) .
In support of the periphilin-synphilin interaction, we found that synphilin-1 and endogenous periphilin show a pancytosolic distribution in HEK 293 cells (Fig. 4a-c) .
Periphilin is also present in the cytoplasm of human neuronal cells (not shown). A partial colocalization of periphilin and synphilin-1 in vivo is also evident in subcellular fractions of adult rat brain obtained by a series of differential centrifugation of rat brain homogenate (Fig. 4d) . Even though periphilin is not enriched in a crude synaptic vesicle fraction (LP2), we can detect significant levels of periphilin in this fraction, suggesting that periphilin and synphilin-1 may interact at the presynaptic terminal (Fig. 4d) . The absence of complete matching in the subcellular distribution of two interacting proteins is not uncommon. For instance, while synphilin-1 is enriched in the LP2 fraction [25] , its interactor α-synuclein is mainly located in the LS2 fraction of mouse and rat brain [29] .
In addition, we find periphilin in LB, similar to synphilin-1 [30] . Although Fig. 5a shows a positive staining for periphilin mainly in the halo, the core is also slightly stained. In other LB, an even more intense staining of the core could be detected. Conversely, synphillin-1 is found predominantly in the core with less but still visible staining in the halo. Structural or chemical requirements for proteins to become part of the different compartments of a LB are still to be defined. As both proteins do occur within the LB, there is at least indirect support of an interaction of the two proteins, even in their aggregated forms.
It is established that synphilin-1 displays an antiapoptotic effect in neuronal and HEK 293 cells by reducing 6-OHDA-and staurosporine-induced caspase-3 activation [12] . This led us to investigate whether periphilin might exert a similar effect and whether it influences the function of the synphilin-1 protein. Indeed, we found that periphilin significantly reduces caspase-3 activity, both under basal conditions and 6-OHDA treatment (Fig. 7) . Cotransfection of periphilin to stable synphilin-1-transfected cells did not result in a synergistic antiapoptotic effect, neither under basal conditions nor under 6-OHDA stimulation (Fig. 7) . The absence of a functional crosstalk between synphilin-1 and periphilin concerning apoptosis could be due to the fact that periphilin might control a synphilin-dependent function unrelated to the ability to modulate cell death. Since not much is known about other functions of synphilin-1, it can only be speculated that the analysis of another functional paradigm will unmask a functional crosstalk between both proteins.
Mutational studies of the periphilin gene revealed a single point mutation causing a K69E substitution in two patients of one small PD family. Three unaffected members of this family do not carry the mutation. The substitution has not been found in a total of 800 chromosomes of control individuals. An extended mutation analysis of further 361 PD patients did not reveal an additional mutation carrier suggesting that the K69E mutation is not frequent among PD patients. As the periphilin gene maps close to the PARK8 locus, we excluded LRRK2 mutations in the two affected cousins carrying the K69E substitution (data not shown). Although we have established the periphilin protein as new interactor of synphilin-1, it still needs to be shown if other PD families or sporadic PD patients carry the K69E mutation or other aberrations in the periphilin gene to underline its relevance for the pathogenesis of PD. Such mutation studies are also necessary to clarify, if the K69E mutation is, indeed, disease causing in the described family, which cannot be judged to date. So far, we have not found any evidence that the K69E mutation influences the interaction with synphilin-1 or the antiapoptotic function of periphilin. Further studies will help to demonstrate if Fig. 7 Periphilin reduces basal and 6-OHDA-induced levels of caspase-3 activity. a Stably expressing mock-transfected or synphilin-1-transfected HEK 293 cells were transiently cotransfected with wt or mutant periphilin or empty vector and treated without or with 200 µM 6-OHDA for 6 h. Subsequently, caspase-3 activity was monitored. b Immunological profile of synphilin-1, periphilin, and tubulin in stable mock-transfected and wt synphilin-1 expressing HEK 293 cells transiently cotransfected with wt or mutant periphilin or empty vector. Note that synphilin-1 is cleaved by caspase-3 activity which is increased in response to 6-OHDA stimulation. Therefore, synphilin-1 expression is decreased under 6-OHDA treatment. Bars, means ± standard deviation of three independent experiments performed in triplicate (n=9). ***p<0.001; **p<0.005; *p<0.05; ns nonsignificant. Asterisks above bars indicate significance levels with respect to HEK Mock plus pcDNA under basal conditions. One arbitrary unit corresponds to the release of 4 nmol of 7-amino-4-methylcoumarin periphilin interacts with other PD-associated proteins and if the K69E mutation alters these interactions. Additionally, other cellular functions of periphilin remain to be elucidated in order to better understand its functions related to the brain.
In summary, we provide first evidence that the periphilin protein interacts with synphilin-1 and that periphilin might be a new small piece in the huge unsolved PD puzzle.
